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Purpose: To compare the global gene expression patterns in uninfected and fungus-infected mouse corneas at the onset
of Candida albicans keratitis.
Methods: Fungal keratitis was generated by scarifying the corneal epithelium of BALB/c mice followed by topical
inoculation with Candida albicans. Corneal infection was allowed to progress for one day, and total RNA was then
extracted from excised corneas. Microarray was performed to detect 45,102 murine genes and processed to identify genetic
regulation of signaling pathways. Selected genes encoding interleukins (IL), chemokine ligands, and other cytokines were
confirmed by quantitative real-time reverse transcriptase polymerase chain reaction (RT–PCR).
Results: Compared to mock-inoculated control eyes, genetic microarray analysis of Candida albicans keratitis showed
that 3,977 genes (8.8%) changed at least twofold and 1,672 genes (3.7%) changed at least fourfold. Hierarchical clustering
identified that upregulated genes affected immune and inflammatory responses, intercellular signaling, and cellular
proliferation. Pathways having more than 20% of their genes significantly upregulated signaled leukocyte extravasation,
increased interleukin production, and affected toll-like receptors. Upregulated transcript levels for IL-1β and IL-6 were
confirmed by real-time RT–PCR.
Conclusions: Host gene expression during the initial stage of Candida albicans keratitis involves pathways contributing
to acute inflammation mediated by interleukins and other signals of leukocyte recruitment. This murine study confirms
the involvement of innate immunity in the cornea during the initiation of Candida albicans keratitis.
Fungal keratitis is a vision-threatening disease [1]. Often
due to filamentous fungi in the tropics, corneal infection due
to  Candida  albicans  has  a  worldwide  distribution  [2].
Although linked to environmental exposure, especially in the
setting of injury or keratopathy [3], the pathogenesis of fungal
keratitis  is  not  fully  understood.  Fungal  virulence  factors
allow growth and invasion into the corneal stroma [4,5], but
host  responses  also  contribute  to  the  pathophysiology  of
corneal  disease.  Studies  have  recently  shown  that  matrix
metalloproteinases [6,7] and other inflammatory mediators
have  key  roles  in  the  progression  and  outcome  of
keratomycosis.  To  gain  further  insight  into  the  molecular
processes of keratomycosis, this study investigated the global
genetic expression pattern at the onset of Candida albicans
keratitis.
Corneal  infection  by  Candida  albicans  triggers  an
inflammatory response that leads to visual loss in more than
half  of  affected  eyes  despite  therapy  [2].  The  prompt
inflammatory response consists predominantly of neutrophils
[8], although lymphocytes and macrophages are also involved
[9]. Our studies suggest that proinflammatory mediators play
important roles at the onset of Candida albicans keratitis, but
the early molecular events that are involved in the corneal and
immune responses remain unclear. Therefore, we examined
the early transcriptional profile of the fungus-infected cornea
in comparison to controls. Observed changes in the corneal
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transcriptome  were  categorized  to  suggest  potentially
important  pathways  contributing  to  corneal  inflammation
during fungal keratitis.
Gene  microarray  methodology  has  evolved  as  an
important technique to investigate the mechanisms for many
ocular disorders including microbial keratitis [10,11]. In this
study, we systematically evaluated the host gene expression
during the early stage of Candida albicans keratitis in a mouse
model.  To  identify  molecular  cascades  of  potential
importance in pathogenesis, we compared corneas of mice
that developed fungal keratitis after epithelial scarification to
uninfected,  scarified  controls.  Results  were  validated  for
selected genes encoding interleukins and other cytokines.
METHODS
Experimental fungal keratitis: A human isolate of Candida
albicans  strain  SC5314  [12]  was  grown  on  Sabouraud
dextrose agar (Difco, Detroit, MI) for three days at 25 °C.
Yeasts  were  harvested  and  diluted  in  sterile  phosphate-
buffered saline (PBS) to yield 2×105 colony-forming units
(CFU)/μl  [12].  Thirty  adult,  female  BALB/c  mice  six-  to
eight-weeks old (Harlan Sprague-Dawley, Houston, TX) were
anesthetized  intraperitoneally  with  rodent  combination
anesthesia, and the corneas of right eyes were superficially
scarified [13]. A 5 µl inoculum (1×106 CFU) of Candida
albicans  was  applied  to  the  scarified  cornea  to  induce
experimental keratitis. An equivalent volume of sterile PBS
diluent was applied to mock-infected controls. Animals were
treated in accordance with the ARVO Statement for the Use
of Animals in Ophthalmic and Vision Research, and protocols
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1792were  approved  by  the  Baylor  College  of  Medicine
Institutional Animal Care and Use Committee. The severity
of keratomycosis was categorized at 24 h post-inoculation
(p.i.)  [13]  when  mice  were  sacrificed  and  right  eyes
enucleated.
RNA extraction: Mouse corneas were dissected at 24 h p.i.,
and surrounding tissues were removed. Corneas were pooled
in sets of five for total RNA extraction with triplicate groups
being  prepared  for  Candida  albicans-infected  and  mock-
infected control groups. RNA was extracted from each pooled
sample using RNeasy MicroKit (Qiagen, Valencia, CA), and
samples  were  treated  with  DNase  (Qiagen)  and  stored  at
−80 °C until use.
Microarray analysis: Microarray analysis was performed in
the Microarray Core Facility of Baylor College of Medicine
(Houston,  TX).  RNA  samples  with  acceptable
spectrophotometric ratios (OD 260/280 ratios greater than 2.0
and 260/230 ratios greater than 1.5) and good electrophoretic
profiles  were  used  for  microarray  analysis.  Affymetrix
Genechip  (Affymetrix,  Santa  Clara,  CA)  protocols  were
applied to qualified samples for two cycles of amplification.
The double-stranded cDNA end product was processed with
an in vitro transcription kit (Affymetirx) to produce biotin-
labeled  cRNA  that  was  quantified  with  a  ND-1000
spectrophotometer  (NanoDrop  Technologies,  Wilmington,
DE). Labeled cRNA (15 μg) was fragmented and rechecked
for  concentration.  A  hybridization  mixture  containing
Affymetrix spike-in controls and fragmented labeled cRNA
was hybridized overnight at 45 °C with rotation at 60 rpm then
washed and stained with a streptavidin and R-phycoerythrin
conjugate  stain  on  a  fluidics  station  450  (Affymetrix).
Following  signal  amplification  with  biotinylated
antistreptavidin, stained arrays were scanned and recorded
using Affymetrix GCOS software version 1.4 (Affymetrix)
then  adjusted  and  analyzed  with  BioConductor  software
[14]. Pairwise comparisons were made between infected and
mock-infected control groups. Raw p values were adjusted by
the Benjamini-Hochberg method for 5% false discovery rate
to yield adjusted p values [15]. The criteria for significance of
differentially regulated genes were established as greater than
or equal to a twofold change with an adjusted p value of less
than or equal to 0.05. Pathways were analyzed (Ingenuity
Systems, Redwood City, CA) to determine the ratio of known
genes within each pathway that were significantly upregulated
during Candidas albicans keratitis relative to the total number
of known genes.
Reverse transcription of RNA and quantitative real-time RT-
PCR:  Total  RNA  isolated  from  corneas  one  day  after
inoculation was spectrophotometrically quantified at 260 nm.
The first-strand cDNA was synthesized from 0.4 μg of total
RNA with Ready-To-Go You-Prime First-Strand Beads (GE
Healthcare, Princeton, NJ) and random hexamers (Applied
Biosystems, Foster City, CA). Real-time polymerase chain
reaction  (RT-PCR)  was  performed  using  TaqMan  Assays
(Table 1) and TaqMan Gene Expression Master Mix and
Assays  (Applied  Biosystems).  Primers  specific  for
interleukins,  IL-1β,  IL-6,  and  IL-23α;  chemokine  ligands,
CCL4 and CCL7; chemokine receptors, CCR3 and CCR5; and
transforming growth factor-beta 2 (TGF-β2) gene transcripts
(Applied Biosystems) were used to quantify gene expression
levels. The threshold cycle (CT) for each target mRNA was
normalized  to  glyceraldehyde-3-phosphate  dehydrogenase
(GAPDH) mRNA and averaged. Gene expression levels were
calculated from normalized CT results, and mean results were
used to determine relative fold changes between experimental
groups.  Two-group  comparisons  were  analyzed  with
Student’s t-test. A p value  less than or equal to 0.05 was
considered statistically significant.
RESULTS
Experimental  post-traumatic  keratomycosis:  All  animals
infected  with  Candida  albicans  strain  SC5314  developed
signs of keratitis by 24 h p.i. Mean±standard deviation (SD)
disease  severity  scores  of  three  independent  Candida
albicans-infected  groups  (five  per  group)  were  8.0±0.7,
8.8±0.8,  and  8.2±0.8.  Based  upon  one-way  ANOVA,  no
significant  difference  occurred  among  the  three  groups
(p=0.27), and the overall mean ocular disease severity was
TABLE 1. OLIGONUCLEOTIDE PRIMERS USED FOR REAL-TIME RT–PCR.
Gene (Symbol) Assay ID Amplicon length
Interleukin 1 beta (IL-1β) Mm00434228_m1 90
Interleukin 6 (IL-6) Mm00446191_m1 124
Chemokine (C-C) ligand 4 (CCL4) Mm00443111_ml 70
Chemokine (C-C) ligand 7 (CCL7) Mm00443113_ml 122
Chemokine receptor 3 (CCR3) Mm01216172_m1 98
Chemokine receptor 5 (CCR5) Mm01216171_ml 78
Interleukin 23 alpha (IL-23α) Mm00518984_m1 61
Transforming growth factor beta 2 (TGF-β2) Mm01321739_m1 109
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH ) Mm99999915_gl 107
The assay ID is from Applied Biosystems.
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17938.3±0.4. No clinical disease or obvious signs of infection was
found in any eyes of the mock-infected control groups.
Corneal gene expression: Triplicate samples of RNA from
five-cornea  pools  of  infected  and  control,  mock-infected
groups met criteria for microarray analysis (Table 2). Overall,
the scaling factor was less than or equal to 3 or within two SD
around the mean, and the average background level was less
than 100 for all samples. All three probes were present for
both housekeeping genes coding for β-actin and GAPDH, and
as expected, two probes were present for the spike-in probe
sets, BioB, BioC, BioD, and CreX. RNA degradation plots
demonstrated similar patterns for all chips (data not shown).
Among  the  total  of  45,102  genes  detected  by  the
Affymetrix Genechip 430.2 microarray, 3,977 genes (8.82%)
in  Candida  albicans-infected  corneas  were  significantly
Figure 1. Distribution of differentially regulated corneal genes. The
microarray results compare the number of corneal genes in mouse
corneas from Candida albicans-infected to the number of corneal
genes  in  mock-infected  control  mouse  corneas.  The  results  are
categorized by expression-level differences in twofold increments.
A  minimum  of  significant  (p≤0.05),  twofold  upregulation  or
significant (p≤0.05) twofold down-regulation was required to be
charted.
(p≤0.05)  and  differentially  (≥2.0  fold  change)  regulated
compared to mock-infected control corneas. Of these, 1,987
genes  were  upregulated,  and  1,990  were  down-regulated.
With a criterion of at least 4.0 fold significant change in the
expression  level,  1,672  genes  (3.71%)  were  differentially
expressed with 1,075 upregulated and 597 down-regulated.
Thirty different genes were significantly upregulated more
than 100 fold (Table 3). The frequency of significant gene
expression followed a bell-shaped distribution (Figure 1).
Gene  expression  levels  were  assigned  to  general
categories based upon known functions of gene products and
the  number  of  genes  expressing  greater  than  or  equal  to
twofold  significant  difference  (p≤0.05).  While  functional
categories included some down-regulated genes, the number
of upregulated genes was consistently more prevalent (Figure
2). Canonical analysis showed that the ratio of significantly
upregulated genes within the pathways ranged from 0.13 to
0.34 (Table 4). Several signaling pathways included genes
that were upregulated fourfold or more (Appendix 1). Similar
Figure 2. Differential upregulation and down-regulation of corneal
genes. Microarray results compare gene expression levels in mouse
corneas from Candida albicans-infected compared to corneas from
mock-infected  controls.  The  results  were  assigned  to  general
categories based upon the known functions of the gene products. The
number  of  genes  expressing  a  twofold  or  greater  significant
difference (p≤0.05) is plotted for the listed categories. Red bars
represent the number of genes significantly down-regulated, and
black bars represent the number of genes significantly upregulated.
TABLE 2. RESULTS OF RNA QUALITY CONTROL EVALUATION.
Experimental
      group
Scaling
 factor
   Average
background
PCall





Infected 1 2.5 64.5 56.9 2.6 2.7
Infected 2 2.5 54.1 54 2 2.1
Infected 3 2.4 55.8 52.4 1.8 1.9
Control 1 2.4 60.6 52.9 2.8 2.6
Control 2 2.4 54.9 53.7 3 2.6
Control 3 4.6 53.7 47.2 3.1 2.8
Triplicate samples of five-cornea pools were used from Candida albicans-infected or mock-infected control animals. PCall %
is the percent of probe sets that are called “present” by Affymetrix’s algorithm. The 3′ to 5′ ratio is the 3′-end to 5′-end probe
intensity ratio. The number of “present” probes for housekeeping probe sets (β-actin and GAPDH) was 3, and the number of
spike-in probe sets (BioB, BioC, BioD, and CreX) was 2.
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and real-time reverse transcriptase (RT)–PCR analysis (Table
5), although CCR3 expression differed between the infected
and mock-infected corneas.
DISCUSSION
Fungal  keratitis  comprises  a  dynamic  interaction  between
microorganisms and host [16]. Because most mechanisms that
mediate the pathogenesis of fungal keratitis have not been
elucidated, we explored the global gene expression during
Candida albicans corneal infection with the use of genetic
microarray. To control for the effects of corneal trauma [17,
18],  we  compared  corneas  having  post-traumatic  fungal
keratitis with scarified controls. At 24 h p.i., approximately
9% of genes were significantly expressed twofold or more and
nearly 4% were differentially altered at least fourfold.
Our findings complement previous studies of microbial
keratitis. Huang and Hazlett [11] found that approximately
10% of genes changed significantly 24 h after the onset of
Pseudomonas aeruginosa keratitis in BALB/c and B6 mice.
Wang  and  colleagues  [10]  exposed  heat-killed  spores  of
Aspergillus fumigatus to excised pieces of BALB/c mouse
cornea and noted that several host genes were substantially
upregulated including those encoding interleukin cytokines
such  as  IL-3.  These  gene  expression  studies  imply  that
microbial keratitis involves synchronized host processes that
affect several aspects of inflammatory and immune responses,
intercellular communication, and cellular metabolism.
Toll-like  receptors  (TLRs)  may  carry  out  the  initial
recognition of fungi at the corneal surface [19]. After binding
microbial pathogens [20,21], TLRs can induce intracellular
cascades that give rise to inflammatory cytokines. Several
members of the TLR family that are expressed on the cornea
respond  to  fungal  infection  [22,23],  and  our  preliminary
analysis suggests that TLR pathways are involved in Candida
albicans keratitis.
The recruitment of acute inflammatory cells is a key event
that immediately follows fungal adherence. Among genes
detected by microarray, a quarter of them are involved in
signaling  leukocyte  extravasation,  and  these  genes  were
significantly upregulated. Candida albicans infection triggers
chemotactic  and  other  signaling  cascades  [22]  with  the
nuclear  factor-ĸβ  pathway  having  an  important  role.  This
transcription factor regulates immune responses to infection
and is increased during keratitis [24].
Several mediators of inflammation and wound healing
such as metalloproteinases and interleukins are active in the
initial events of corneal infection. Genes encoding IL-6 and
IL-1β  were  expressed  more  than  300  fold  during  fungal
keratitis. Corneal injury results in the upregulation of IL-1β
[18], and infection further increases its expression [25]. IL-6
TABLE 3. CATEGORIES OF ALL GENES SIGNIFICANTLY UPREGULATED MORE THAN 100 FOLD.
Category Symbol Description GenBank
accession
   Relative
upregulation
p value
Chemokines PPBP Chemokine (C-X-C) ligand 7 AB042817 834.4 0.01
CCL3 chemokine (C-C) ligand 3 AA895994 374.3 0.04
CXCL3 chemokine (C-X-C) ligand 3 AK144158 291.7 0.04
CCL4 chemokine (C-C) ligand 4 AF128218 145.2 0.011
CXCL5 chemokine (C-X-C) ligand 5 AK044397 132.4 0.05
Metalloproteinases MMP13 matrix metallopeptidase 13 AK150728 375.4 0.001
ADAM8 a disintegrin and metallopeptidase domain 8 AK089086 108 0.01
MMP8 matrix metallopeptidase 8 AK089234 102.5 0.0003
Interleukin cytokines IL-6 interleukin 6 AK089780 245.4 0.009
IL-1β interleukin 1 beta AK156396 136.8 0.03
OSM oncostatin M AK087945 122.7 0.006
Leukocyte chemotaxis FPR1 formyl peptide receptor 1 AK137714 145.2 0.01
FPR-RS2 formyl peptide receptor, related sequence 2 AF071180 132.8 0.05
SELL selectin, lymphocyte AK137509 114.3 0.01
Leukocyte surface molecules CLEC4D C-type lectin domain family 4, member d AF061272 118.2 0.04
Ig superfamily receptors CLEC4E C-type lectin domain family 4, member e AB024717 180 0.02
TREM1 triggering receptor expressed on myeloid cells 1 AF241219 136.4 0.0063
Cell proliferation molecules CSF3 colony stimulating factor 3 (granulocyte) AK145177 114.3 0.001
HMGA2 high mobility group AT-hook 2 AC153362 106.8 0.002
G0S2 G0/G1 switch gene 2 AK003165 104.7 0.01
Neuro-hormone mediators or receptors IRG1 immunoresponsive gene 1 AK036446 328.9 0.03
NPPB natriuretic peptide precursor type B AB039044 204.1 0.000002
MRGPRA2 MAS-related GPR, member A2 AK156116 202.6 0.008
INHBA inhibin beta-A AC154742 201.9 0.0003
Histamine synthesis HDC histidine decarboxylase AB039880 251.5 0.03
Prostaglandin synthesis PTGS2 prostaglandin-endoperoxide synthase 2 AC114655 106.2 0.004
Intracellular molecules CYP4F18 cytochrome P450, family 4, subfamily f, polypeptide
18
AF233647 164.8 0.01
SAMSN1 SAM domain, SH3 domain and nuclear localization
signals, 1
AC166831 145.7 0.002
PLEK pleckstrin AF073294 142.6 0.003
Protein transport SLC15A3 solute carrier family 15, member 3 AF121080 114.2 0.02
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infection  [26].  By  validating  our  microarray  results  for
selected  genes  that  had  variable  expression  patterns,  we
showed  that  the  early  stage  of  fungal  keratitis  involves
upregulation  of  proinflammatory  interleukins  in  a  pattern
similar  to  that  during  bacterial  keratitis  [11].  We  also
confirmed that TGF-β does not appear to be altered during
early fungal infection [27]. While injury induces interleukins
and related cytokines, infection enhances the production of
selected mediators of acute inflammation.
Our studies of fungal keratitis are consistent with other
models of Candida albicans infection. Expression patterns of
genes coding for IL-6 and chemokine receptors markedly
increase soon after the onset of Candida albicans exposure
[27], and this increase likely contributes to the recruitment and
influx  of  leukocytes  into  the  infected  cornea.
Histopathological  evidence  also  indicates  that  corneal
inflammation during the incipient stage of Candida albicans
keratitis is a manifestation of the innate immune response
[13].
In parallel with pathways promoting ulcerative keratitis,
the cornea has anti-inflammatory mechanisms for inhibiting
NF-ĸβ activity and dampening the effects of inflammatory
mediators.  Although  increased  during  bacterial  keratitis,
IL-10  was  not  significantly  altered  24  h  after  corneal
inoculation with yeasts, possibly because of a different kinetic
profile. However, approximately one-third of genes involved
in  IL-10  signaling  were  significantly  upregulated  during
Candida albicans keratitis. Other inflammatory suppressors







   Number
upregulated
     genes Ratio
Leukocyte extravasation 16 191 44 0.23
NF-κβ 15.5 141 38 0.27
Interleukin 10 13.2 68 23 0.34
Interleukin 6 12.5 90 27 0.3
Acute-phase response 11.3 171 36 0.21
B cell receptor 6.7 144 26 0.18
Toll-like receptor 6.6 50 14 0.28
Integrin 6.1 188 30 0.16
Natural killer cell 6 112 19 0.17
Granulocyte-macrophage colony-
stimulating factor
5.8 63 15 0.24
Transforming growth factor beta 4.9 84 16 0.19
Chemokine 4.7 75 15 0.2
Interleukin 2 4.5 52 12 0.23
Insulin-like growth factor 1 3.8 94 15 0.16
T cell receptor 3.5 100 15 0.15
Epidermal growth factor 3 47 9 0.19
Vascular endothelial growth factor 3 93 13 0.14
Interleukin 4 3 69 11 0.16
JAK/STAT 2.6 112 19 0.17
Apoptosis 2.5 62 8 0.13
TABLE 5. REAL-TIME RT-PCR CONFIRMATION OF MICROARRAY.
Gene (Symbol) Microarray Real-time RT-PCR p value
Interleukin 1 beta (IL-1β) 342.4±477.5 378.0±317.4 0.92
Interleukin 6 (IL-6) 376.0±295.4 388.1±318.9 0.96
Chemokine (C-C) ligand 4 (CCL4) 228.7±175.5 200.9±172.2 0.85
Chemokine (C-C) ligand 7 (CCL7) 60.9±51.7 14.9±9.8 0.21
Chemokine receptor 3 (CCR3) -6.0±3.5 14.5±4.3 0.004
Chemokine receptor 5 (CCR5) 1.1±1.1 2.3±0.9 0.20
Interleukin 23 alpha (IL-23α) 9.1±3.3 14.2±9.9 0.44
Transforming growth factor beta 2 (TGFβ2) 1.8±1.0 -1.8±3.7 0.19
Mean fold change ± standard deviation, comparing infected to mock-inoculated control corneas.
Molecular Vision 2008; 14:1792-1798 <http://www.molvis.org/molvis/v14/a211> © 2008 Molecular Vision
1796such as suppressor of cytokine signaling protein-3 were also
upregulated.
Pathways of immune recognition may also be activated
by fungal infection. We confirmed that IL-23 increases during
Candida  albicans  keratitis  [27].  Expression  of  this  T-cell
regulatory molecule suggests that adaptive immunity may be
involved in candidiasis, although to a lesser degree than innate
immune reactions [28].
Our  study  provides  evidence  for  a  likely  scenario  of
molecular  events  during  early  fungal  keratitis.  Soon  after
corneal surface injury and exposure to viable fungi, fungal
components are recognized by host receptors such as lectins
and  toll-like  receptors.  Binding  by  ligands  induces
intracellular  cascades  that  activate  NF-ĸβ,  which,  in  turn,
upregulates genes responsible for inflammatory responses.
Corneal levels of interleukins and other cytokines rapidly
increase. Neutrophils and macrophages are recruited toward
the  site  of  infection,  helping  to  kill  fungi  but  releasing
chemokines  that  contribute  to  corneal  ulceration  and
neovascularization.
In summary, gene microarray analysis is a useful means
for  understanding  the  molecular  biology  of  ocular
inflammatory disease. Candida albicans keratitis involves the
induction of genes encoding several interrelated pathways,
and  this  investigation  provides  insight  into  the  pivotal
reactions during the onset of fungal keratitis. Characterizing
this coordinated sequence of events can provide insight into
the pathogenesis of fungal keratitis that will open up new
opportunities for therapeutic interventions.
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Appendix 1. Upregulated signaling pathways in Candida albicans keratitis
compared with mock controls.
To access the data, click or select the words “Appendix 1”. This will initiate the download of a (pdf) archive that
contains the file.
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